Nightstar Therapeutics Ltd. logo

Nightstar Therapeutics Ltd.

Nightstar is a leading clinical-stage gene therapy company focused on developing and commercializing novel, one-time treatments for patients suffering from rare inherited retinal diseases that would otherwise progress to blindness.

[stock_market_widget type=”leaderboard” template=”color-frame” color=”yellow” assets=”NITE” api=”yf” style=”font-size: 15px”]

0
Management
0
Technology
0
Deals/Partnering
0
Research Pipeline
0
Funding
BioStartup's Score 0 / 50

KEY DETAILS

Websitehttps://www.nightstartx.com
Founded2014
Disease Focus
Development Stage
STOCK CODENASDAQ: NITE
Address
215 Euston Road NW1 2BE
London
United Kingdom
Email
Contact Number
+44 0 20 7611 2077

[atom_linkedin linkedin_option=”CompanyInsider” linkedin_id=”https://in.linkedin.com/company/nightstarx-limited” connections=”true” suffix=””]